Cover; Title page; Copyright information; Table of contents; Meet the author; Acknowledgments; Foreword; What the reviewers say; Introduction; The structure of this book; Learning features; 1 Mental illness; 1.1 Introduction; 1.2 Aetiology of mental illness; 1.3 Neurodevelopmental theories; Neurons and neurotransmitters; 1.4 Clinical decision-making in practice and medicine management; 2 Drugs used in psychoses; 2.1 Introduction; 2.2 Mechanism of action; Biochemical theories; Glutamate hypothesis; Dopamine hypothesis; Typical antipsychotics (first-generation antipsychotics)
Text of Note
3.3 Dose and administration3.4 Adverse effects and management; Tricyclic antidepressants; Adverse effects and management; Selective serotonin reuptake inhibitors; Adverse effects and management; Serotonin-noradrenaline reuptake inhibitors; Adverse effects and management; Examples of discontinuation symptoms; Tetracyclic (noradrenergic and specific serotonergic antidepressants); Adverse effects and management; Aminoketone (bupropion); Adverse effects and management; Monoamine oxidase inhibitors; Precautions, side effects and management; Reversible inhibitor of monoamine oxidase type A
Text of Note
Atypical antipsychotics (second-generation antipsychotics)2.3 Dose and administration; Rapid tranquillisation; Antipsychotic drugs in depot preparation; Prescribing antipsychotic drugs to smokers; 2.4 Adverse effects and management; Extrapyramidal side effects; Dystonia; Management of dystonia; Akathisia; Management of akathisia; Drug-induced parkinsonism; Management of drug-induced parkinsonism; Tardive dyskinesia; Management of tardive dyskinesia; Anticholinergic drugs; Non-extrapyramidal adverse effects of antipsychotic drugs; Muscarinic 1 receptor block; Cardiovascular effects
Text of Note
Side effectsSerotonin syndrome; 3.5 Differences in therapeutic effects of antidepressants; 4 Drugs used in dementia; 4.1 Introduction; 4.2 Mechanism of action; Acetylcholinesterase inhibitors; 4.3 Dose and administration; 4.4 Adverse effects and management; Acetylcholinesterase inhibitors; Polypharmacy in the older person; Antipsychotic therapy in the care of the older person; 4.5 Memantine (NMDA receptor antagonist); Mechanism of action of memantine; Concomitant use of cholinesterase inhibitors and memantine; Adverse effects and management of memantine; 5 Drugs used in bipolar disorders
Text of Note
Weight gain and mental illnessGender; Socioeconomic status and level of education; Age; Other contributing factors to weight gain in people with mental illness; Weight gain monitoring and management; Endocrine adverse effects; Allergic and dermatological effects; Haematological adverse effects; Obligatory monitoring for clozapine therapy; Clozapine alert; Other adverse effects of clozapine; Neuroleptic malignant syndrome; 2.5 Medication adherence in mental health settings; 3 Drugs used in depression; 3.1 Introduction; 3.2 Mechanism of action; Monoamine theory of depression
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
An essential text for all trainee and registered health professionals who require knowledge and understanding of drugs used in the treatment of mental health conditions for prescribing or administering purposes.